CD44 and neoplasm: Six-week-old female BALB/c nude mice were injected subcutaneously with MDA-MB-231, RT-R-MDA-MB-231, and CD24−/low/CD44+ cells, and tumor volumes and body weights were measured three times weekly beginning on the 7th day after injection, as described in the Materials and Methods section.